These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care? Hopkins MM; Martin PA Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421 [No Abstract] [Full Text] [Related]
4. [Not Available]. Fischer A Drug Res (Stuttg); 2017 Nov; 67(S 01):S9. PubMed ID: 29069674 [No Abstract] [Full Text] [Related]
5. [Reelin dysfunction in neuropsychiatric diseases and its potential as a drug target]. Hattori M Nihon Yakurigaku Zasshi; 2012 Mar; 139(3):99-102. PubMed ID: 22451463 [No Abstract] [Full Text] [Related]
7. Challenges in developing drugs for neurological and psychiatric disorders. Simon NG; Brownstein MJ Prog Neurobiol; 2017 May; 152():1-2. PubMed ID: 28442128 [No Abstract] [Full Text] [Related]
8. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Heyes S; Pratt WS; Rees E; Dahimene S; Ferron L; Owen MJ; Dolphin AC Prog Neurobiol; 2015 Nov; 134():36-54. PubMed ID: 26386135 [TBL] [Abstract][Full Text] [Related]
9. Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know? Seripa D; Lozupone M; Stella E; Paroni G; Bisceglia P; La Montagna M; D'onofrio G; Gravina C; Urbano M; Priore MG; Lamanna A; Daniele A; Bellomo A; Logroscino G; Greco A; Panza F Expert Opin Drug Saf; 2017 Dec; 16(12):1373-1385. PubMed ID: 29025271 [TBL] [Abstract][Full Text] [Related]
10. Genetics of neurological and psychiatric disorders. Res Publ Assoc Res Nerv Ment Dis; 1983; 60():1-300. PubMed ID: 6823523 [No Abstract] [Full Text] [Related]
11. Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come? Lozupone M; Panza F; Stella E; La Montagna M; Bisceglia P; Miscio G; Galizia I; Daniele A; di Mauro L; Bellomo A; Logroscino G; Greco A; Seripa D Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):259-277. PubMed ID: 27718745 [TBL] [Abstract][Full Text] [Related]
12. [Sex-linked (X-linked) heredity in mental and neurological diseases]. Predo'scu V; Christodorescu D Neurol Psihiatr Neurochir; 1972; 17(5):441-52. PubMed ID: 4656716 [No Abstract] [Full Text] [Related]
13. Cyclooxygenases and cyclooxygenase inhibitors in neurological and psychiatric diseases. Minghetti L Curr Pharm Des; 2008; 14(14):1400. PubMed ID: 18537662 [No Abstract] [Full Text] [Related]
14. [Psychopharmaceuticals in general practice from the neurological and psychiatric viewpoint]. Wieck HH; Zenglein R Z Allgemeinmed; 1975 Mar; 51(9):418-25. PubMed ID: 1163064 [No Abstract] [Full Text] [Related]